article thumbnail

The potential of AI in pharma R&D

Pharmaceutical Technology

Companies that combine rapid innovation with speedy but safe trials can gain a multifaceted competitive advantage. According to Deloitte , 76% of biopharma companies invest in AI for clinical development. Modern knowledge management complements AI AI has almost unlimited potential for pharma companies.